CONTEXT AND RELEVANCE
Well-executed field studies provide the best data possible for decision-making before moving to pilot release studies using insects themselves as the control agent.1–3 The quality of the studies and their data become particularly important as the paradigm for novel vector control moves beyond methods of research to product development.4 This conceptual shift from localized to population-level control, gives baseline, longer-term monitoring and/or specific bio-ecological studies substantial value to future area-wide release campaigns using genetic technologies aimed at vector control.3,5–7
Mark, release, recapture (MRR) studies are particularly useful in understanding bio-ecological features of a target population, and additionally how a laboratory-reared mosquito may perform in a natural environment.8–10 Although there is always some variability in data from such field studies of natural populations, improving reliability and conformity of methods employed enhances reliability and confidence in any results used in decisions.
Historically, field entomology (FE) studies may have allowed for flexibility in operational planning to respond to real-world conditions encountered. “Local adaptations” of method, timing, and technique to fit the constraints or objectives of the context, however, may fail to achieve terms and conditions of a permit and reduce data comparability between studies or sites within larger research initiatives.7 Here, we share part of our experiences of proceeding with more rigorous field studies that inform critical decisions regarding novel vector control with released mosquitoes; we hope for feedback on options to establish and demonstrate field study preparedness and reliability of data.
AN EVOLVING CONTEXT
The discussion surrounding the move from laboratory to field studies of an innovative vector control method is developing fast.11–13 Gene drive strategies introduced through release of laboratory-reared mosquitoes or other vectors present additional questions, and this conversation is taking place in a public arena where many views are expressed.14
The role of field studies such as MRR in building knowledge for pilot releases is well established. When any genetically modified insect release is planned, additional, important factors come into play such as public perception of safety,15,16 stakeholder engagement,17–19 approvals from institutional ethics boards and biosafety committees,20,21 and preparation of regulatory dossiers aimed at gaining permit approval.22
Against a long background of FE studies aimed at understanding mosquito biology, managers are often unaccustomed to the level of additional paperwork and verification to demonstrate good practice or to justify moving forward with studies comprising a step-wise progression into field use. In recent years in projects such as Target Malaria, https://targetmalaria.org, there has been specification of FE guidance documents and the development of training to support these.7 This documentation is most effectively specified through collaborative process to include a diversity of experience, so that its stipulations are widely achievable and comprehensible. Research initiatives using genetic vector control involve, at each step, international teams and/or teams involving different expertise and background and facing different levels of national and institutional resources†. Clear evidence-sharing within and between teams is a critical factor to successful decision-making in such research collaborations.23 Guidance and training are vital components of such initiatives but may be insufficient to ensure longer term understanding of, and adherence to, such guidance. Furthermore, such research teams need to comprehensively document compliance for both public and funder confidence.
THE AUDIT PRACTICE AND EXPERIENCE
We developed an audit approach to verify administrative readiness, correct use of standard operating procedures (SOPs)/technical guidance, and appropriate performance of tasks in a specific context; that of evaluating “preparedness” for field studies. This synthesized various translational practices to create a detailed audit checklist, divided by themes or areas of responsibility and on a readily accessible Microsoft Excel platform.
The audit sequence followed the plan for an MRR as an example of a field study that should be standard and consistent. The process started with administrative preparation, and then continued through production of mosquitoes for release, transport to the study site, the actual field study phase, and laboratory identification of recaptured specimens to wrap-up and feedback. We viewed this from the start as a tool for internal learning and management rather than the one forming evidence for regulators: a tool to support confidence within field research teams, laboratory collaborators, and funders.
The approach was applied in the first example in one disease-endemic partner country in the Target Malaria research consortium, in conjunction with a trial run of an MRR study using wild-type mosquitoes in advance of approval for any genetically modified strain. In this case, the audit topics, including the specific questions developed by the various subject specialists involved, were supplied in advance to the FE, stakeholder engagement, and operational teams being audited because of the formative nature of this approach.24 As the formality of the audit process was particularly unfamiliar for the field teams, being more well known in laboratory practice, we first undertook a supportive and formative pre-audit to identify elements where specific improvement was essential a priori. This also emphasized areas in which understanding of objectives or the reasons behind the context was important for promoting compliance. We allowed 3 months between pre-audit and audit to give time for improvements in practice and additional training, as needed.
The audit was then carried out during an MRR study using a non-transgenic laboratory strain, with the core process taking place over approximately 3 days. Later follow-up was based on review of subsequent study reports and community feedback elements. Each topic matched relevant guidance, SOPs, permit terms and conditions, and other key criteria (see Table 1 for topics and sample questions), and the evidence required was predetermined. For the audit itself, a mixed, external team of experienced auditors with specialist responsibilities, along with representatives from other teams on the pathway to audit, was found to be effective for both checks and further formative feedback. The auditors used the detailed checklist to indicate the level of practice observed for each topic or question and provided comments to supplement the yes/no/partial/or not applicable result. Each auditor noted on the audit form their evidence for the level assigned, including particular documents, records, or simple observations by the auditor. A follow-up report and response plan completed the audit process.
Audit sections and topics with representative sample questions
Audit sections | Topic | Example question |
---|---|---|
Administrative preparation | Regulatory | Have the terms and conditions of the permission been met or responded to? |
Preparation | Have any attendant National Biosafety Authority (NBA) observers been briefed in the study? | |
Ethics | Have the Institutional Biosafety Committee and the Institutional Ethics Committee given permission for the study? | |
Organisation | Is there an available administration plan with contact details of participants? | |
Emergencies | Is there a communication chain of command in the event of an emergency? | |
SE/communications | Have the field team been briefed on the requirements of the permit, the biosafety measures required, and the contingency plan? | |
Insectary and production | Colony confirmation | Has the level of insecticide resistance in colony mosquitoes been evaluated and found comparable or less than field levels? |
Setup | Are there sufficient supplies for colony augmentation? | |
Augmentation | Has a calendar for the activities required for augmentation been prepared? | |
Marking | Have the mosquitoes been colour-marked and has this application been verified? | |
Packing | Are a sufficient number of cages available to take to the field for releases? | |
Record keeping | Chain of custody: Has the insectary logbook been signed to confirm packing, number of coolers, and exit? | |
Transport out | Transport | Are two (or more) vehicles available, fit, and equipped correctly for transport? |
SE/communications | Can the drivers or key vehicle staff explain this activity within the parameters of the project message policy? | |
Vehicle | Is there a copy of the incident procedure (Contingency Plan) in each vehicle? | |
Journey | Have the mosquitoes arrived in a good condition for the study? | |
Record keeping | Chain of custody: Was the Transport Record signed to acknowledge arrival at site? | |
Field preparation | Field laboratory | Is the field laboratory fit for purpose and lockable? |
Field team | Has the welfare of the field team been well considered? | |
Preparation | Is the village acceptance of this study current and verified? | |
Organisation | Are the method-specific training records available for all team members? | |
Field activities | Release | Were the mosquitoes released at the stipulated time and place? |
Swarm capture (by sweep net) | Were the swarm sampling locations available to the field team in advance? | |
Pyrethroid spray catch | Was the pyrethroid spray catch procedure in accordance with the Field Guidance? | |
Mosquito sorting | Are the samples being accurately tracked and documented? | |
Record keeping | Is the sample labeling procedure correct? | |
Transport back | Transport | Was the principal investigator/project manager kept informed of departure from field and arrival at the laboratory |
Communication | Were the village authorities informed of the completion of the field study? | |
Vehicle | Are the cargo’s accompanying documents present and correct? | |
Journey | Was any incident handled appropriately? (if there were any) | |
Insectary | Did the unloading happen as required? | |
Record keeping | Was the transport record signed to acknowledge arrival at the insectary? | |
Insectary and identification | Re-entry | Have the transport cages been appropriately cleaned for return to containment? |
Preparation | Have the staff members performing the identification of field samples appropriately trained in molecular techniques? | |
Analyses | Are laboratory notebooks and methodologies being correctly completed during the analyses? | |
Sample handling | Are samples being correctly labeled and stored? | |
Record keeping | Are the data sheets being correctly completed, correctly saved, and backed-up? | |
Wrap-up | Management | Were the principal investigator and project manager contactable throughout this study? |
Regulatory | Has the relevant authority (NBA or Ministry of the Environment) been informed of the end of the study? | |
Record keeping | Have the data sheets been submitted to the parent project within the time stipulated? | |
SE | Has the summary of initial study been shared with the village and local staff? | |
Field entomology | Has the monitoring plan been agreed and is it being followed? |
SE = represents stakeholder engagement.
In this instance, the formative process of pre-audit and subsequent summative audit (in which substantial and convincing adherence to guidance was recorded) led to auditors reaching agreement with the on-site team and the central management of the research consortium to recommend proceeding to the next step when regulatory permits allowed. Following this experience, teams can continue to use the audit framework to support subsequent “spot check” internal verification. In larger consortia, teams could apply this structure to audit each other, which is useful when resources do not allow for full external auditor teams to visit on a routine basis.
THE FIELD SITUATION
In many research institutions, field and insectary/laboratory teams are often overlapping and used on several projects. This creates additional challenges to compliance when different projects or objectives require different standards of consistency and rigor. Although an overarching Code of Practice for the field from one project can provide guidance on a wide range of factors, this is hard to apply across different funder requirements and would require broad institutional support and enforcement. We found that a field audit as described could verify the level of preparedness for many things easily lost from sight in both routine practice and under the pressures of additional preparation and documentation requirements. Such common sense issues as the driver having a mobile phone with credit and everyone carrying personal ID cards can be overlooked, which is where simple check lists come into play. The use of between-team auditing may have additional advantage as there are circumstances in which effective participation of certain external auditors may be limited by sensitivities to increased numbers of visitors on site, the language abilities of the auditors and security concerns in more remote areas.
WHAT LIES AHEAD?
This is the beginning of a long path supporting confidence in exploring the potential of genetic vector control technologies. We are working toward full internal confidence before attempting to fulfill the anticipated requirements of regulatory frameworks that are not yet fully defined. In this example, we have briefly described the development of an audit process to take place before the field study, which is perceived as more important when using novel technologies. Although audit timing and coverage of topics may be worth further discussion, we recommend similar approaches for field studies that may face greater scrutiny than that has been the case historically. With an audited and more formalized path in place, field studies can provide trusted data and support both internal and external confidence in the process. Here, the improvements in performance of tasks at all stages of the study and the quality and consistency of supporting documentation seen between the first formative audit and later summative audit were convincing in indicating clear benefit to the preparation process. Demonstrable quality of process validated by such an audit is an important foundation to the next steps in delivering reliable proof-of-principle studies in the field for the emerging novel vector control strategies. We hope for an ongoing discussion that will inform, advise, and refine the process.
Acknowledgements:
This work was carried out under the auspices of Target Malaria, which receives core funding from the Bill & Melinda Gates Foundation and from the Open Philanthropy Project Fund, an advised fund of Silicon Valley Community Foundation.
REFERENCES
- 1.↑
James S et al. 2018. Pathway to deployment of gene drive mosquitoes as a potential biocontrol tool for elimination of malaria in sub-Saharan Africa: recommendations of a scientific working group. Am J Trop Med Hyg 98: 1–49.
- 2.
WHO/TDR and FNIH, 2014. Guidance Framework for Testing Genetically Modified Mosquitoes. 159. Available at: http://r4d.dfid.gov.uk/Output/197475/Default.aspx. Accessed July 13, 2019.
- 3.↑
Facchinelli L et al. 2013. Field cage studies and progressive evaluation of genetically-engineered mosquitoes. PLoS Negl Trop Dis 7: e2001.
- 4.↑
World Health Organization, 2017. The Evaluation Process for Vector Control Products. WHO/HTM/GMP/201713. Available at: https://www.who.int/malaria/publications/atoz/evaluation-process-vector-control-products/en/. Accessed July 13, 2019.
- 5.↑
Lees RS et al. 2014. Review: improving our knowledge of male mosquito biology in relation to genetic control programmes. Acta Trop 132 (Suppl): S2–S11.
- 6.
Ferguson HM, Dornhaus A, Beeche A, Borgemeister C, Gottlieb M, Mulla MS, Gimnig JE, Fish D, Killeen GF, 2010. Ecology: a prerequisite for malaria elimination and eradication. PLoS Med 7: 1–7.
- 7.↑
Collins CM et al. 2018. Comparability of data at wide spatial scales: codeveloping comparable and coherent baselines for mosquito monitoring across Africa. Dakar, Senegal: Multilateral Initiative on Malaria.
- 8.↑
Epopa PS, Millogo AA, Collins CM, North A, Tripet F, Benedict MQ, Diabate A, 2017. The use of sequential mark-release-recapture experiments to estimate population size, survival and dispersal of male mosquitoes of the Anopheles gambiae complex in Bana, a west African humid savannah village. Parasit Vectors 10: 376.
- 9.
Guerra CA et al. 2014. A global assembly of adult female mosquito mark-release-recapture data to inform the control of mosquito-borne pathogens. Parasit Vectors 7: 1–15.
- 10.↑
Facchinelli L, North AR, Collins CM, Menichelli M, Persampieri T, Bucci A, Spaccapelo R, Crisanti A, Benedict MQ, 2019. Large-cage assessment of a transgenic sex-ratio distortion strain on populations of an African malaria vector. Parasit Vectors 12: 70.
- 11.↑
Hendrichs J, Vreysen MJB, Enkerlin WR, Cayol JP, 2005. Strategic options in using sterile insects for area-wide integrated pest management. Sterile Insect Technique: Principles and Practice in Area-Wide Integrated Pest Management. Dordrecht, The Netherlands: Springer.
- 12.
Scott MJ, Morrison NI, Simmons GS, 2014. Transgenic approaches for sterile insect control of dipteran livestock pests and lepidopteran crop pests. Transgenic Insects: Techniques and Applications. Wallingford, UK: CABI.
- 13.↑
Scott MJ, Benedict MQ, 2016. Concept and history of genetic control. Adelman ZN, ed. Genetic Control of Malaria and Dengue. London, UK: Academic Press, 31–54.
- 14.↑
Heitman E, Sawyer K, Collins JP, 2016. Gene drives on the horizon. Applied Biosafety 21: 173–176.
- 15.↑
Benedict MQ, Charlwood JD, Harrington LC, Lounibos LP, Reisen WK, Tabachnick WJ, 2018. Guidance for evaluating the safety of experimental releases of mosquitoes, emphasizing mark-release-recapture techniques. Vector-Borne Zoonotic Dis 18: 39–48.
- 16.↑
Duman-Scheel M, Eggleson KK, Achee NL, Grieco JP, Hapairai LK, 2018. Mosquito control practices and perceptions: an analysis of economic stakeholders during the zika epidemic in Belize, Central America. PLoS One 13: e0201075.
- 17.↑
Tindana PO, Singh JA, Tracy CS, Upshur REG, Daar AS, Singer PA, Frohlich J, Lavery JV, 2007. Grand challenges in global health: community engagement in research in developing countries. PLoS Med 4: e273.
- 18.
Thizy D et al. 2019. Guidance on stakeholder engagement practices to inform the development of areawide vector control methods. PLoS Negl Trop Dis 12: 1–11.
- 19.↑
Kolopack PA, Parsons JA, Lavery JV, 2015. What makes community engagement effective?: lessons from the eliminate dengue program in Queensland Australia. PLoS Negl Trop Dis 9: e0003713.
- 20.↑
Kilama WL, 2010. Health research ethics in malaria vector trials in Africa. Malar J 9 (Suppl 3): S3.
- 21.↑
Singh JA, 2019. Informed consent and community engagement in open field research: lessons for gene drive science. BMC Med Ethics 20: 1–12.
- 22.↑
ANBAA, 2018. Gene drive technology as a potential biocontrol tool for vector-borne diseases in sub-Saharan Africa. Proceedings of the Second African Biosafety Leadership Summit. Nairobi, Kenya: Association of National Biosafety Agencies in Africa (ANBAA).
- 23.↑
Quinlan MM, 2019. Delivery of a Novel Intervention for Vector Control: Learning Frameworks to Support Complex Decisions. PhD Thesis, Imperial College London, UK.
- 24.↑
Arens A, Randal EJ, Beasley MS, 2012. Auditing and Assurance Services: An Integrated Approach. London, UK: Pearson Learning Solutions.
- 25.↑
Quinlan MM et al. 2018. Studies of transgenic mosquitoes in disease-endemic countries: preparation of containment facilities. Vector-Borne Zoonotic Dis 18: 21–30.
- 26.↑
Quinlan MM, Birungi J, Coulibaly MB, Diabaté A, Facchinelli L, Mukabana WR, Mutunga JM, Nolan T, Raymond P, Traoré SF, 2018. Containment studies of transgenic mosquitoes in disease endemic countries: the broad concept of facilities readiness. Vector-Borne Zoonotic Dis 18: 14–20.